A novel role for the inflammasome in the immunopathogenesis of Candida vaginitis
A novel role for the inflammasome in the immunopathogenesis of Candida vaginitis
批准号:
9206120
负责人:
Brian M Peters
金额:
$10.8万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-01-15 至 2018-12-31
关键词:
AffectAgeAlternative TherapiesAnimalsAntifungal AgentsAspartic EndopeptidasesBacterial AdhesinsBeliefBiologicalBurning PainCASP1 geneCandidaCandida albicansCareer MobilityChronicClinicalConsultCytokine SignalingDataDefectDevelopmentDiseaseEpithelialEpitheliumFacultyFemale of child bearing ageFoundationsFundingFunding OpportunitiesGeneticGenetic TranscriptionGlyburideGoalsHealthHistologicHuman VolunteersImmuneImmune responseImmunityImmunologicsIn VitroInfectionInflammasomeInflammationInflammatoryInflammatory ResponseInnate Immune ResponseInterleukin-1 betaInterleukinsK22 AwardKnockout MiceKnowledgeLactate DehydrogenaseLeadLiquid substanceManuscriptsMeasurementMediatingMediator of activation proteinMedicalMentorsMissionMolecularMorphogenesisMucous MembraneMusNational Institute of Allergy and Infectious DiseaseNeutrophil InfiltrationOralOral mucous membrane structureOutcomeOutputPainPeptide HydrolasesPharmacologyPositioning AttributePredispositionPreventive therapyProcessProductionPruritusPublicationsPublishingQuality of lifeReceptor SignalingRecruitment ActivityRecurrenceRednessResearchResearch PersonnelRoleSeveritiesSignal PathwaySignal TransductionSignaling MoleculeSurfaceSymptomsTestingTissuesTranslational ResearchVaginaVaginal DouchingVaginal ItchingVaginitisVirulenceVirulence FactorsVulvovaginal CandidiasisWomanWorkYeastsadaptive immunitycareercombatcostcytokinedesignexperiencefaculty researchfungusimmunopathologyin vivoinflammatory markerinnovationmembermigrationmouse modelneutrophilnew therapeutic targetnovelnovel strategiesnovel therapeutic interventionoverexpressionpathogenprofessorprogramspublic health relevancereproductiveresponseskillstenure tracktreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Candida albicans, the primary causative agent of fungal vaginitis, will affect 75% of all women of reproductive age at least once in their lifetime. Static activity of commonly deployed antifungals and chronic infections are of growing concern; therefore, alternative therapies are crucially needed. Despite long-held beliefs that susceptibility to Candida vaginitis resulted from defects in
adaptive immunity, it has recently been shown that the clinical immunopathology (i.e. itching, burning, pain, discomfort, redness of the vaginal mucosa) associated with Candida vaginitis is triggered by robust recruitment of polymorphonuclear leukocytes (PMN) to the vaginal epithelium. Using a mouse model of vaginitis, the S100 alarmins were identified as key signaling molecules in in this hallmark PMN response. However, recent studies using mice deficient in S100 alarmin production still responded with vigorous PMN recruitment when challenged with C. albicans. Therefore, a fundamental gap in knowledge still exists as to the alternative and/or complementary mechanism(s) by which neutrophils are recruited to the vaginal epithelium during Candida vaginitis.
One possible process by which inflammation can be triggered at epithelial surfaces is by activation of the inflammasomes, a group of cytosolic cellular receptors that signal and initiate innate immune responses. Therefore, the objective of this proposal is to 1) demonstrate that the Nlrp3 inflammasome is a key early mediator of the innate inflammatory response and to 2) identify specific hypha-associated C. albicans virulence factors that result in inflammasome activation in the vaginal epithelium. Guided by strong preliminary data, these aims will test our central hypothesis that activation of the inflammasome induced by the C. albicans yeast-to-hypha transition during vaginitis potentiates exacerbated neutrophil influx and pro-inflammatory cytokine signaling in the vaginal epithelium. All aims will utilize a well-established mouse model of vaginitis to test our hypotheses. Under the first aim, genetic or pharmacologic blockade of discrete targets in the inflammasome signaling cascade will be utilized to elucidate signaling pathways contributing to Candida vaginitis. Successful disruption of inflammasome-dependent signaling will be assessed via measurement of inflammatory markers (PMNs, Interleukin-1b, S100 alarmins). In the second aim, morphogenesis-competent C. albicans strains deficient in specific hypha-associated virulence factors (secreted proteinases or adhesins) or strains locked in the yeast form but over-expressing these key identified hyphal virulence factors will be utilized to assess their required role for generating robust innate immune responses in vivo. This approach is innovative because it examines both host and fungal processes required for immune responses associated with Candida vaginitis and seeks to identify inflammasome function in the vaginal mucosa. This proposed work is significant because it will ultimately aid in the identification of novel signaling pathways that may serve as new therapeutic targets for such infections.
This work will also provide a strong foundation on which the candidate can attain an independent academic research program. The candidate's immediate career goal is to successfully transition from a non-tenure track junior faculty member to a tenure-track Assistant Professor position studying the host innate immune response and molecular mechanisms associated with fungal vaginitis. His long-term career goal is to attain a tenured research faculty
position to direct and maintain a well-funded, translational research team that studies innate immune mechanisms to fungal pathogens at the mucosal interface. In order to attain these career goals, aside from conducting the research described above, the candidate will assemble and maintain a supportive mentoring/consulting team that will aid in the successful completion of the research, hone the development of grantsmanship skills leading to effective funding opportunities, and accelerate the publication of high-impact data. Thus, these career goals fulfill
the NIAID's mission to identify novel therapeutic approaches to combat fungal disease and to support junior investigators in making a career transition to independent faculty status under the K22 award mechanism.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1007/s40496-016-0078-y
发表时间:
2016-03
期刊:
Current oral health reports
影响因子:
--
作者:
[Willems HM, Xu Z, Peters BM]
通讯作者:
Peters BM
Lipid emulsion composition as a determinant of fungal biofilm formation and incidence of candidemia
-
批准号:10388392
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2021
-
负责人:Brian M Peters
-
依托单位:
Lipid emulsion composition as a determinant of fungal biofilm formation and incidence of candidemia
-
批准号:10213517
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2021
-
负责人:Brian M Peters
-
依托单位:
Candidalysin: a key mediator of Candida vaginitis immunopathology
-
批准号:10229531
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2018
-
负责人:Brian M Peters
-
依托单位:
Candidalysin: a key mediator of Candida vaginitis immunopathology
-
批准号:9767658
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2018
-
负责人:Brian M Peters
-
依托单位:
Candidalysin: a key mediator of Candida vaginitis immunopathology
-
批准号:9594689
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2018
-
负责人:Brian M Peters
-
依托单位:
A novel role for the inflammasome in the immunopathogenesis of Candida vaginitis
-
批准号:8820695
-
项目类别:
-
资助金额:$15.98万
-
财政年份:2016
-
负责人:Brian M Peters
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: